The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Torasemide in Chronic Heart Failure: Results of the TORIC Study
Open accessAbstract
Background: Diuretics such as torasemide are commonly used to treat chronic heart failure (CHF). Aims: The objective of the TOrasemide In Congestive Heart Failure (TORIC) Study was to investigate the safety, tolerability and efficacy of torasemide in CHF patients compared to furosemide or other diuretics in an open-label, non-randomised, post-marketing surveillance trial. Methods: The present analysis shows the findings of 1377 patients with New York Heart Association (NYHA) class II–III CHF who received diuretic therapy with torasemide 10 mg/day orally (n-778) vs. patients who received furosemide 40 mg/day orally (n-527) or other diuretics (n-72) on top of their existing standard CHF therapy for 12 months. Besides safety and tolerability, efficacy was assessed by documentation of mortality, morbidity, functional class and serum potassium levels every 3 months. Results: TORIC confirmed the safety and tolerability of torasemide in CHF patients. Mortality was significantly lower in the torasemide (n-17, 2.2%) than in the furosemide/other diuretics group (n-27, 4.5%) (P<0.05). Functional improvement as assessed by NYHA class was observed in more patients who received furosemide torasemide (n-356, 45.8%) than those who received furosemide/other diuretics (n-223, 37.2%) (P-0.00017). At the end of the study abnormally low serum potassium levels were observed in fewer torasemide (n-95, 12.9%) than furosemide/other diuretics patients (n-102, 17.9%) (P-0.013). Conclusion: Torasemide is safe and well tolerated in CHF patients. Although not designed as a mortality study, TORIC suggests a lower mortality amongst CHF patients treated with torasemide compared to furosemide/other diuretics. A functional improvement and a lower incidence of abnormal serum potassium levels were also observed in patients receiving torasemide as compared to those receiving furosemide/other diuretics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
COMMITTEE MEMBERS, WILLIAMS, J. F., BRISTOW, M. R., FOWLER, M. B., FRANCIS, G. S., GARSON, A., GERSH, B. J., HAMMER, D. F., HLATKY, M. A., LEIER, C. V., et al. (1995) · Circulation · doi:10.1161/01.cir.92.9.2764 · Cited by 663
Remme, W. J., & Swedberg, K. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00231-8 · Cited by 452
Preoperative Assessment of Patients with Known or Suspected Coronary Disease
Mangano, D. T., & Goldman, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332607 · Cited by 415
Consensus recommendations for the management of chronic heart failure
Packer, M., & Cohn, J. N. (1999) · Excerpta Medica eBooks · Cited by 360
MacFadyen, R. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00091-6 · Cited by 339
Packer, M., & Miller, A. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00358-6 · Cited by 278
Murray, M. D., Deer, M. M., Ferguson, J. A., Dexter, P. R., Bennett, S. J., Perkins, S. M., Smith, F. E., Lane, K. A., Adams, L. D., Tierney, W. M., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00903-2 · Cited by 255
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Rangaswami, J., Bhalla, V., Blair, J. E. A., Chang, T. I., Costa, S., Lentine, K. L., Lerma, E. V., Mezue, K., Molitch, M., Mullens, W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000664 · Cited by 1,409
Konstam, M. A., Kiernan, M. S., Bernstein, D., Bozkurt, B., Jacob, M., Kapur, N. K., Kociol, R. D., Lewis, E. F., Mehra, M. R., Pagani, F. D., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000560 · Cited by 945
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ono, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 704
Metadata
- Authors
- Cosín, J., & Díez, J.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-01
- Volume
- 4
- Issue
- 4
- Pages
- 507-513
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2079740085
- Cited by
- 276
- References
- 16
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Torasemide in Chronic Heart Failure: Results of the TORIC Study. https://app.cochat.ai/papers/10.1016/s1388-9842(02)00122-8
- The paper
- Cosín, J., & Díez, J. (2002). Torasemide in Chronic Heart Failure: Results of the TORIC Study. European Journal of Heart Failure. https://doi.org/10.1016/s1388-9842(02)00122-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.